Sandoz today announced the introduction of tacrolimus capsules, a generic equivalent of Prograf®, in the US. Tacrolimus is an immunosuppressive treatment used to help prevent rejection of a kidney or liver transplant.

Sinclair Pharma PLC (LSE: SPH) announced the US launch of its treatment for seborrheic dermatitis by Promius Pharma, the dermatology division of Dr Reddy’s Laboratories Inc.

That slightly alarmist view is only partly true. Unlike big Indian auto and IT companies, pharma industry has still not reached the inflexion point where it can challenge big MNCs. Till a few years ago it was believed Indian pharma companies' highly profitable generic business model,they were able to corner a large share of market for drugs going off patent, and occasionally challenged patents through Para IV filings in the US, would allow them to build financial muscle.

The emerging markets are the final frontier for pretty much every industry. The huge untapped markets have lots of potential, and pharmaceutical companies have jumped in full tilt.